SonoSite garners ATL cash
SonoSite of Bothell, WA, last month received $12 million from former parent company ATL Ultrasound, also of Bothell. The payment terminates ATL's financial obligations to SonoSite under the conditions of the 1998 agreement that established SonoSite as an
SonoSite of Bothell, WA, last month received $12 million from former parent company ATL Ultrasound, also of Bothell. The payment terminates ATL's financial obligations to SonoSite under the conditions of the 1998 agreement that established SonoSite as an independent company (SCAN 4/15/98). SonoSite received an initial cash influx of $18 million from ATL at the time of spin-off. ATL has been a subsidiary of Philips since July 1998, when the company agreed to sell to Philips for $800 million (SCAN 8/5/98).
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
